This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Studying the evolution of high-grade serous ovarian cancer after targeted therapy
This is a test.
Charting the cellular spacial landscape in rare ovarian cancer
This is a test.
Identifying biomarkers of immunotherapy response in ovarian clear cell carcinoma
This is a test.
Advancing Research Alongside Patient Partners: Next-Generation Best Practices for Effective Collaboration in Health Research
This is a test.
Testing a novel HER2-targeted combination treatment for ovarian cancer
This is a test.
Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer
This is a test.
Testing a novel treatment target in clear cell ovarian cancer
This is a test.
Understanding the experience of previvors receiving care at a specialized centre
This is a test.
NEOCATS trial: Targeting the targets with a combination of three treatments
This is a test.
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
